Mean (±SE) plasma concentrations of soluble TNF- (pg/mL) and monocyte membrane-anchored TNF- after intravenous injection of LPS in subjects either receiving GI5402 (□) or placebo (•) given 20 minutes before LPS challenge (lot G, 4 ng/kg). Pvalue indicates the difference between treatment groups. NS, nonsignificant.